REG - Creightons PLC - Directorate Change

CreightonsAnnouncement

27/11/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231127:nRSa6708Ua&default-theme=true

RNS Number : 6708U  Creightons PLC  27 November 2023

27 November 2023

 

CREIGHTONS plc ("Creightons" or the "Company")

 
Board
Change

 

Creightons plc (LSE: CRL), manufacturers of personal care, beauty, and
fragrance products, announces that Bernard Johnson's  employment has
terminated and he is no longer a board member. The board is considering
options regarding the appointment of a new Managing Director but in the
meantime the Company wishes to assure all stakeholders including staff,
customers and shareholders, that the Company continues to be managed
effectively by the executive team.

 

This announcement contains inside information as stipulated under the UK
version of the Market Abuse Regulation No 596/2014 which is part of English
law by virtue of the European Union (Withdrawal) Act 2018, as amended. On
publication of this announcement via a regulatory information service, this
information is considered to be in the public domain.

Enquiries - Analysts and Investors:

Nicholas O'Shea, Director, Creightons Plc
                             01733 281000

Roland Cornish / Felicity Geidt, Beaumont Cornish Limited
                0207 628 3396

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOANKABDPBDDNDB